Evaluation of Havachobe ointment effect in healing diabetic foot ulcers

Evaluation of Arnebia euchroma ointment effect in healing diabetic foot ulcers compared to simple dressings

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250728066662N1

Enrollment

Registered

2025-09-01

Start date

2025-08-23

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot ulcer.

Interventions

Intervention 1: Intervention group: Abu Khalsa ointment was applied in the amount necessary to create a 3 mm thick layer on sterile gauze and placed on the wound surface. Intervention 2: Control grou

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having a grade 2 diabetic foot ulcer in one or more areas

Exclusion criteria

Exclusion criteria: -Currently smoking Taking anticoagulant medication in the last 3 months Taking immunosuppressive medication in the last 3 months Having a coagulation disorder such as hemophilia Taking medications or supplements containing vitamin C, A or ZINK in the last 3 months Having chronic vascular insufficiency with a cause other than diabetes Hb A1C more than 10 No taking broad-spectrum oral antibiotics during this period of wound treatment Abscess or swelling in the wound area

Design outcomes

Primary

Measure	Time frame
Wound size. Timepoint: Before the start of the aforementioned interventions, the wound size is determined and recorded as the product of the largest length and the largest width of the wound in centimeters, as well as the presence or absence of erythema (redness) around the wound. At the end of days 10 and 21 (end of the intervention), the wound size is determined and recorded again. Method of measurement: Ruler.	—

Measure

Time frame

Wound size. Timepoint: Before the start of the aforementioned interventions, the wound size is determined and recorded as the product of the largest length and the largest width of the wound in centimeters, as well as the presence or absence of erythema (redness) around the wound. At the end of days 10 and 21 (end of the intervention), the wound size is determined and recorded again. Method of measurement: Ruler.

—

Secondary

Measure	Time frame
Number of cases of erythema. Timepoint: Before the start of the aforementioned interventions, the wound size is determined and recorded as the product of the largest length and the largest width of the wound in centimeters, as well as the presence or absence of erythema (redness) around the wound. At the end of days 10 and 21 (end of the intervention), the wound size is determined and recorded again. Method of measurement: Observation and photography.	—

Measure

Time frame

Number of cases of erythema. Timepoint: Before the start of the aforementioned interventions, the wound size is determined and recorded as the product of the largest length and the largest width of the wound in centimeters, as well as the presence or absence of erythema (redness) around the wound. At the end of days 10 and 21 (end of the intervention), the wound size is determined and recorded again. Method of measurement: Observation and photography.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMonireh Seraj

Ghoum University of Medical Sciences

dr.seraj.1400@gmail.com+98 31 4274 7977

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026